Expression, processing, and secretion of the neuroendocrine VGF peptides by INS-1 cells

被引:48
|
作者
Possenti, R
Rinaldi, AM
Ferri, GL
Borboni, P
Trani, E
Levi, A
机构
[1] Univ Roma Tor Vergata, Dept Neurosci, I-00133 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Internal Med, I-00133 Rome, Italy
[3] Univ Cagliari, Dept Cytomorphol, I-09124 Cagliari, Italy
[4] CNR, Inst Neurobiol, I-00137 Rome, Italy
关键词
D O I
10.1210/en.140.8.3727
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The neurotropin-inducible gene vgf is expressed in neuronal and endocrine tissues. It encodes a secretory protein that is proteolytically processed in neuronal cells to low molecular mass polypeptides. In the present report, we show that vgf is expressed in different insulinoma cell lines and in normal rat pancreatic islets. In the insulinoma-derived beta-cell line INS-1, vgf messenger RNA was transcriptionally up-regulated by increased levels of intracellular cAMP, but not by the addition of glucose (20 mM) or phorbol 12-myristate 13-acetate (100 nM). Furthermore, nerve growth factor failed to stimulate vgf gene expression. In INS-1 cells, the VGF protein was shown to be processed in a post endoplasmic reticulum compartment to produce a peptide profile similar to that seen in neurons. The release of such VGF peptides occurred at a low rate in the absence of secretory stimuli (<2%/h). A 3-fold increase in the rate of release was seen after the addition of glucose (15 mM), a 4-fold increase was seen after (Bu)(2)cAMP (1 mM), and a 6-fold increase was seen after phorbol la-myristate 13-acetate (100 nM). These results indicated that insulin-containing cells produce VGF-derived peptides that are released via a regulated pathway in response to insulin secretagogues.
引用
收藏
页码:3727 / 3735
页数:9
相关论文
共 50 条
  • [21] Effects of adrenaline and tolbutamide on insulin secretion in INS-1 cells under voltage control
    Kampermann, J
    Herbst, M
    Ullrich, S
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2000, 10 (1-2) : 81 - 90
  • [22] Knockdown of iPLA2β expression in INS-1 cells by siRNA leads to attenuation of glucose induced insulin secretion
    Bao, SZ
    Ramandham, S
    Jin, W
    Zhang, S
    Turk, J
    [J]. DIABETES, 2005, 54 : A682 - A682
  • [23] Glucotoxicity - A regulator of GLUT2 and insulin gene expression as well as insulin secretion in INS-1 cells.
    Brock, B
    Gregersen, S
    Hermansen, K
    [J]. DIABETOLOGIA, 1996, 39 : 204 - 204
  • [24] Overexpression of PLC isoforms in INS-1 cells
    Gasa, R
    Trinh, K
    Newgard, C
    [J]. DIABETES, 1998, 47 : A257 - A257
  • [25] Differential impact of acute and chronic lipotoxicity on gene expression in INS-1 cells
    Xiao, JZ
    Gregersen, S
    Pedersen, SB
    Hermansen, K
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (02): : 155 - 162
  • [26] Expression of HNF4α variants in pancreatic islets and Ins-1 β cells
    Huang, Jianmin
    Karakucuk, Vildan
    Levitsky, Lynne L.
    Rhoads, David B.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2008, 24 (07) : 533 - 543
  • [27] Loureirin B activates GLP-1R and promotes insulin secretion in Ins-1 cells
    Ding, Yanting
    Xia, Sijing
    Zhang, Han
    Chen, Qin
    Niu, Bing
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (02) : 855 - 866
  • [28] Induction of SGK1 by dexamethasone is accompanied by inhibition of insulin secretion and of proliferation in INS-1 cells
    Ranta, F
    Berchtold, S
    Lang, F
    Ullrich, S
    [J]. DIABETOLOGIA, 2004, 47 : A166 - A166
  • [29] PP-2A is associated with synapsin I in INS-1 cells and regulates insulin secretion
    Parameswara, V
    Thangthaeng, N
    Bhatt, H
    Easom, R
    [J]. DIABETES, 2003, 52 : A383 - A383
  • [30] Assessment of anaplerotic pathways and insulin secretion in INS-1 cells by 13C-NMR
    Lepine, R
    Shulman, G
    Cline, G
    [J]. DIABETES, 2003, 52 : A378 - A378